ClinicalTrials.gov record
Recruiting Not applicable Interventional Accepts healthy volunteers

EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations

ClinicalTrials.gov ID: NCT06716580

Public ClinicalTrials.gov record NCT06716580. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 1:39 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT06716580
Recruitment status
Recruiting
Study type
Interventional
Phase
Not applicable
Lead sponsor
Dana-Farber Cancer Institute
Other
Enrollment
1,000 participants

Conditions and interventions

Interventions

  • Circulating Tumor DNA (ctDNA) Assay Device

Device

Eligibility (public fields only)

Age range
40 Years to 80 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2025
Primary completion
Aug 31, 2027
Completion
Aug 31, 2030
Last update posted
Dec 9, 2025

2025 – 2030

United States locations

U.S. sites
6
U.S. states
1
U.S. cities
4
Facility City State ZIP Site status
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 Not yet recruiting
Dana-Farber Cancer Institute Boston Massachusetts 02215 Recruiting
Massachusetts General Hospital Boston Massachusetts 02215 Not yet recruiting
Dana-Farber Cancer Institute at Steward St. Elizabeth's Brighton Massachusetts 02135 Not yet recruiting
Dana-Farber Cancer Instiute Merrimack Valley Methuen Massachusetts 01844 Not yet recruiting
Dana-Farber Cancer Institute South Shore South Weymouth Massachusetts 02190 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06716580, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 9, 2025 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06716580 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →